Search filters

List of works by Maria Carmela Piccirillo

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

scientific article published on 27 February 2017

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

scientific article published on October 2013

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

scientific article published on 12 August 2015

Angiogenesis Inhibitors in NSCLC.

scientific article published on 21 September 2017

BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer

scientific article

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

scientific article

Cetuximab in non-small-cell lung cancer

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials

scientific article

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

scientific article published on January 2014

EGFR mutations in lung cancer: from tissue testing to liquid biopsy

scientific article published on January 2015

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

scientific article

Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer

scientific article

Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial

scientific article published on 20 April 2009

First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment

scientific article

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

scientific article

Gefitinib in non small cell lung cancer

scientific article

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

scientific article published on July 2013

Methodological aspects of lung cancer clinical trials in the era of targeted agents

scientific article published on 28 October 2009

New biological treatments for gynecological tumors: focus on angiogenesis

scientific article published on 06 January 2014

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

scientific article

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

scientific article published on 14 April 2015

Pharmacokinetic evaluation of capecitabine in breast cancer

scientific article published on 10 January 2013

Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial

scientific article published on January 1, 2012

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

scientific article published on 31 January 2012

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

scientific article published on 21 August 2017

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

scientific article published in May 2013

Survival After Surgical Treatment of Lung Cancer Arising in the Population Exposed to Illegal Dumping of Toxic Waste in the Land of Fires ('Terra dei Fuochi') of Southern Italy

scientific article

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

scientific article published on 26 January 2015

Time spent for activation of non-profit studies in oncology in Italy

scientific article

Treatment of small cell lung cancer

scholarly article by Alessandro Morabito et al published September 2014 in Critical Reviews in Oncology Hematology

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial

scientific article